DHSC:OLS_Liquid Biopsy Testing and its Impact in Primary Care
DHSC, London publishes Research & Development work continuously — 5 notices, roughly one every 6 days. This is a stream to watch, not a cycle to wait for.
31% of DHSC, London’s awards go to a supplier it has used before.
Which is the argument for getting on the list rather than winning this one. The incumbent is rarely the last winner — it is the roster. See the retention odds by category →
DHSC (Department of Health) and OLS (Office for Life Sciences) is seeking to commission a supplier that will conduct a research project to understand the clinical impact of liquid biopsy tests on the early diagnosis of cancer in symptomatic patients presenting with abdominal symptoms in primary care.
We anticipate that delivery will require a tripartite consortium comprising an independent evaluator and a liquid biopsy provider, with the capability to identify, establish, and manage engagement with point-of-care settings (NHS) for patient recruitment and participation.
The Office for Life Sciences seeks to run a market engagement to assess the number of liquid biopsy providers with diagnostic tests at a later stage of development, with published evidence of efficacy in patients with suspected cancer symptoms.
This research project would act as a use case for the OLS’ Cancer Healthcare Goals programme when developing future funding competitions which aim to address a market failure in the evaluation of cancer diagnostic and therapeutic technologies in the latter stages of development.
This initial market questionnaire aims to, at a high level, understand the scale, knowledge and capability of the market along with what appetite there is for delivering this service.
DHSC/OLS would like to use this market engagement to inform the specification for commissioning a supplier for what is an anticipated 18-month contract.
This is not a call for competition, but an opportunity to gather feedback to better understand market capabilities, refine the procurement strategy, and encourage supplier engagement.
Interested parties can access the relevant documents via the Atamis system at https://health-family.force.com/s/Welcome using the contract reference.
Suppliers may also submit the completed questionnaire through Atamis but must be registered on the system to do so.
Alternatively, questionnaires can be submitted by email to ccsinbox@dhsc.gov.uk, quoting “Liquid Biopsy” no later than 30/06/2025 5pm
What the notice asks for
Suppliers may also submit the completed questionnaire
Suppliers may also submit the completed questionnaire through Atamis but must be registered on the system to do so.
Sentences from the notice that state an obligation, surfaced automatically and shown in the order they appear. Not an exhaustive list — always confirm against the tender documents.
Make the case to bid
Reveal who to approach at DHSC, London, and generate a go-to-market strategy from their news, accounts and people.
Free to start. Named contacts come from published notices; the strategy is generated from the buyer’s news, accounts and people.
The full intelligence dossier
Our agent reads DHSC, London’s accounts, hunts live signals, finds the people who decide — and hands you a bid strategy plus a go-to-market influence plan, including what your team should post this week. You approve every paid step.
Five included while we’re in beta, and the agent asks before it spends on any paid step.
- OCID
- ocds-h6vhtk-054960
- Stage
- planning · Planning
- Source
- Find a Tender
- Buyer ref
- 032641-2025
Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.
Who wins this kind of work
The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.
Top suppliers & buyers in Research & Development
DHSC, London’s tender network